- Home
- ATAT vs PLXS Comparison
ATAT vs PLXS Comparison
Compare ATAT & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATAT | PLXS |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | China | United States |
| Employees | N/A | 20000 |
| Industry | Hotels/Resorts | Electrical Products |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.7B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ATAT | PLXS |
|---|---|---|
| Price | $39.03 | $253.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $49.00 | ★ $206.50 |
| AVG Volume (30 Days) | ★ 1.1M | 306.1K |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | N/A | ★ 56.11 |
| EPS | N/A | ★ 1.51 |
| Revenue | ★ N/A | N/A |
| Revenue This Year | $25.48 | $14.31 |
| Revenue Next Year | $18.11 | $8.29 |
| P/E Ratio | ★ $26.11 | $166.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.48 | $115.83 |
| 52 Week High | $43.17 | $255.01 |
Technical Indicators
Market Signals| Indicator | ATAT | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 56.34 | 75.31 |
| Support Level | $34.31 | $133.51 |
| Resistance Level | $42.89 | N/A |
| Average True Range (ATR) | 1.25 | 7.22 |
| MACD | 0.34 | 2.79 |
| Stochastic Oscillator | 62.72 | 89.77 |
Price Performance
Historical ComparisonAbout ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.
About PLXS Plexus Corp.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.